3P Biopharmaceuticals

Successful Biotech M&A Advisory Services

The Challenge

3P Biopharmaceuticals engaged the experts at PharmaBioSource, Inc. as consultants and advisors to raise 6M Euros to support the growth of the company.

3P Bio is a biologics API contract manufacturing organization (CMO) located in Pamplona, Spain.  3P Bio was seeking funding to support the expansion of its mammalian cell culture and microbial fermentation development capabilities and reactor capacity within its 50,000 SF facility.

The Solution

To assist 3P Bio with its goal of raising financing to support its capital requirements, PharmaBioSource engaged the biologics contract manufacturing and healthcare investment communities to identify an appropriate partner.

We utilized our expertise and extensive contacts within the biologics CMO and Life Sciences Industry to identify a number of potential partners for 3P Bio.

Services provided by the PharmaBioSource team:

  • Business and site assessment
  • Value proposition creation
  • Creation of introductory project teaser
  • Target identification and marketing
  • Prepared Confidential Information Memorandum (CIM)
  • Data room development
  • Managed confidentiality agreements
  • Hosted site visits and meetings with 3P Bio management and investors
  • Deal structure and negotiations
  • Closing

The Results

PharmaBioSource, Inc. identified Infarco, the parent company of Cinfa and one of Spain’s largest generic pharmaceutical companies, as the investment partner for 3P Bio.  Cinfa invested 6M Euros through a joint venture with 3P Bio to develop biosimilar products.

Talk To Us

Whether you’re looking to streamline your business processes, buy or sell a manufacturing facility, or expedite a merger, our expert advisors are here to make it a smooth and favorable experience for you.

Representative Clients

site by Think it First